Form 4: Stryker Corp Executive James Andrew Pierce Reports Acquisition of Common Stock

Group President James Andrew Pierce reports acquisition of Stryker Corp common stock due to achievement of performance goals.

Summary

• James Andrew Pierce, Group President of Stryker Corp, filed a Form 4 on March 13, 2024, reporting a transaction involving Stryker's common stock.
• On March 11, 2024, Pierce acquired 8,499 shares of common stock.
• This acquisition was based on the achievement of pre-established three-year adjusted diluted net earnings per share and sales performance goals.
• The acquired shares vest on March 21, 2024.
• Following the reported transaction, Pierce directly owns 60,461 shares of Stryker common stock.
• Pierce also indirectly owns 508 shares through Son GP, 508 shares through Son AP and 1,524 shares through 401K.

Sentiment

Score: 7

Explanation: The sentiment is positive as the acquisition of shares is based on the achievement of performance goals, indicating confidence in the company's performance. However, it's a routine filing, so the impact is moderate.

Positives

• The acquisition of shares by a company executive, based on performance goals, can be seen as a positive signal, indicating confidence in the company's future performance.
• The achievement of the pre-established three-year adjusted diluted net earnings per share and sales performance goals suggests the company is performing well.

Future Outlook

The document does not contain specific forward-looking statements, but the acquisition of shares based on performance goals suggests an expectation of continued strong performance.

Industry Context

Executive compensation in the medical device industry often includes stock options and grants tied to performance metrics, aligning executive interests with shareholder value. This filing reflects that practice at Stryker.

Comparison to Industry Standards

• Stock awards are a common component of executive compensation packages across the medical device industry.
• Companies like Medtronic, Johnson & Johnson (DePuy Synthes), and Zimmer Biomet also utilize performance-based equity grants to incentivize their executives.
• The specific metrics used (adjusted diluted net earnings per share and sales performance) are typical indicators of financial health and growth in the sector.
• The vesting period of three years is also a standard practice to ensure long-term commitment from executives.

Stakeholder Impact

• The acquisition of shares by an executive can positively influence shareholder sentiment, reflecting confidence in the company's prospects.
• Employees may view the achievement of performance goals and subsequent executive stock acquisition as a positive sign of company success.

Key Dates